Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JIE YANG

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1386719060
CMS profile
334777
Location
NORWICH, CT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$3,541.83

163 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,525.84 162
Education $15.99 1

By paying entity

PY2025 · entire year · sorted by reported total

Page 3 of 4; records 101–150 of 163 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JIE YANG

NPI 1386719060 · CMS profile ID 334777

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

NORWICH, CT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 163 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1386719060?year=2025&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JIE YANG, NPI 1386719060, CMS profile ID 334777. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 163 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1386719060?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). JIE YANG, NPI 1386719060, CMS profile ID 334777. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 163 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1386719060?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
JIE YANG, NPI 1386719060, CMS profile ID 334777, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 163 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1386719060?year=2025&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

163 matching records · $3,541.83 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 163 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 163.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Regeneron Healthcare Solutions, Inc. $19.0704/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1213075356 CMS
Takeda Pharmaceuticals U.S.A., Inc. $20.3604/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223773243 CMS
PFIZER INC. $22.0404/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229179472 CMS
Karyopharm Therapeutics Inc. $14.8504/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246646815 CMS
AstraZeneca Pharmaceuticals LP $17.7604/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206863599 CMS
Janssen Biotech, Inc. $5.6104/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174979346 CMS
Janssen Biotech, Inc. $22.9504/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174979509 CMS
SERVIER PHARMACEUTICALS LLC $23.9304/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229101068 CMS
Agios Pharmaceuticals, Inc. $22.1104/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1253258479 CMS
BeOne Medicines USA, Inc. $13.7304/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202901802 CMS
Coherus Oncology, Inc. $23.3104/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235236025 CMS
Exelixis Inc. $19.8504/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218795831 CMS
Janssen Biotech, Inc. $19.5504/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174979893 CMS
Geron Corporation $26.5004/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238896345 CMS
Daiichi Sankyo Inc. $23.7204/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197098583 CMS
Janssen Biotech, Inc. $21.9404/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174980114 CMS
Incyte Corporation $15.1804/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226118189 CMS
Rigel Pharmaceuticals, Inc. $26.7204/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247372047 CMS
ADC THERAPEUTICS AMERICA, INC. $23.3004/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246117890 CMS
Novartis Pharmaceuticals Corporation $15.5303/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200385346 CMS
Iovance Biotherapeutics, Inc. $28.7203/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251400236 CMS
PFIZER INC. $20.7903/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229066761 CMS
Gilead Sciences, Inc. $5.5003/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234601030 CMS
ABBVIE INC. $28.9003/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204809855 CMS
AstraZeneca Pharmaceuticals LP $24.0303/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206581027 CMS
Gilead Sciences, Inc. $14.0703/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234577071 CMS
SOBI, INC $19.1503/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240248727 CMS
ABBVIE INC. $17.2603/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204809851 CMS
Eisai Inc. $17.4503/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244486129 CMS
Celgene Corporation $21.1003/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184935707 CMS
Novartis Pharmaceuticals Corporation $31.6203/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200385344 CMS
Geron Corporation $28.3503/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238896341 CMS
Rigel Pharmaceuticals, Inc. $26.8603/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247370934 CMS
Astellas Pharma US Inc $21.4603/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238748390 CMS
GlaxoSmithKline, LLC. $20.7903/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190840493 CMS
Merck Sharp & Dohme LLC $16.5603/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238318528 CMS
AstraZeneca Pharmaceuticals LP $14.8503/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206479241 CMS
Janssen Biotech, Inc. $20.8302/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174980202 CMS
Novartis Pharmaceuticals Corporation $19.3802/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200385348 CMS
Genentech USA, Inc. $20.0902/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211524234 CMS
Rigel Pharmaceuticals, Inc. $26.5002/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247369913 CMS
PFIZER INC. $22.0402/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229238124 CMS
AstraZeneca Pharmaceuticals LP $21.7802/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207249838 CMS
AstraZeneca Pharmaceuticals LP $24.6702/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207294841 CMS
AstraZeneca Pharmaceuticals LP $22.3002/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206200990 CMS
Genentech USA, Inc. $13.7702/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211524236 CMS
AstraZeneca Pharmaceuticals LP $29.5202/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207131729 CMS
PFIZER INC. $14.3302/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229067190 CMS
Daiichi Sankyo Inc. $15.3901/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197074617 CMS
Janssen Biotech, Inc. $15.5901/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174978295 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,086.52 142
PY2020 $1,303.42 81
PY2021 $2,086.75 118
PY2022 $2,734.64 141
PY2023 $2,854.51 145
PY2024 $3,452.05 176
PY2025 $3,541.83 163

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $11,268.90 9
PY2023 Principal investigator $39,405.03 4
PY2022 Principal investigator $236,638.07 7
PY2021 Recipient $500.05 1
PY2021 Principal investigator $234,210.15 3
PY2020 Principal investigator $216,406.63 2
PY2019 Principal investigator $1,940.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

9 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Chiesi USA, Inc. $4,000.00 05/09/2024 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGYONCOLOGY ASSOCIATES
A Phase 3, Randomized, Double-Blind, Active and Placebo-Controlled Study on the Use ofCUSA-081for Dysfunctional Central Venous Access Devices (CVADs) No dispute reported 06/30/2026 1148219534
Principal investigator 1 Chiesi USA, Inc. $1,800.00 05/09/2024 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGYONCOLOGY ASSOCIATES
A Phase 3, Randomized, Double-Blind, Active and Placebo-Controlled Study on the Use ofCUSA-081for Dysfunctional Central Venous Access Devices (CVADs) No dispute reported 06/30/2026 1148219536
Principal investigator 1 Chiesi USA, Inc. $500.00 05/09/2024 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGYONCOLOGY ASSOCIATES
A Phase 3, Randomized, Double-Blind, Active and Placebo-Controlled Study on the Use ofCUSA-081for Dysfunctional Central Venous Access Devices (CVADs) No dispute reported 06/30/2026 1148219538
Principal investigator 1 Chiesi USA, Inc. $747.70 03/07/2024 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGYONCOLOGY ASSOCIATES
A Phase 3, Randomized, Double-Blind, Active and Placebo-Controlled Study on the Use ofCUSA-081for Dysfunctional Central Venous Access Devices (CVADs) No dispute reported 06/30/2026 1148216782
Principal investigator 1 Novartis Pharmaceuticals Corporation $752.00 02/29/2024 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY & ONCOLOGY ASSOCIATES
Ribociclib Standard Endocrine therapy in patients with HR HER2 Early BC at High amp Intermediate Risk for Recurrence No dispute reported 06/30/2026 1089689717
Principal investigator 1 Genentech, Inc. $555.00 02/26/2024 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY & ONCOLOGY ASSOCIATES PC
Chemo trastuzumab vs chemo trastuzumab pertuzumab No dispute reported 06/30/2026 1133392826
Principal investigator 1 Chiesi USA, Inc. $971.40 01/17/2024 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGYONCOLOGY ASSOCIATES
A Phase 3, Randomized, Double-Blind, Active and Placebo-Controlled Study on the Use ofCUSA-081for Dysfunctional Central Venous Access Devices (CVADs) No dispute reported 06/30/2026 1148214631
Principal investigator 1 Chiesi USA, Inc. $971.40 01/17/2024 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGYONCOLOGY ASSOCIATES
A Phase 3, Randomized, Double-Blind, Active and Placebo-Controlled Study on the Use ofCUSA-081for Dysfunctional Central Venous Access Devices (CVADs) No dispute reported 06/30/2026 1148214633
Principal investigator 1 Chiesi USA, Inc. $971.40 01/17/2024 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGYONCOLOGY ASSOCIATES
A Phase 3, Randomized, Double-Blind, Active and Placebo-Controlled Study on the Use ofCUSA-081for Dysfunctional Central Venous Access Devices (CVADs) No dispute reported 06/30/2026 1148214635